Why CYCN? Cyclerion Therapeutics, Inc. Analysis, Price & AI Insights | Whystock
CYCN
$3.26-0.05 (-1.51%)
Market ClosedLast close May 1
Cyclerion Therapeutics, Inc., a biopharmaceutical company, develops treatments for serious diseases serious diseases with novel sGC stimulators in both the central nervous system (CNS) and the periphery.